Grosvenor Food & AgTech was part of a £130m Series C financing in San Francisco-based The EVERY Company (EVERY), a leading precision fermentation platform.

Our investment in EVERY – a market leader in developing, formulating and manufacturing animal-free animal proteins for the global food and beverage industry – enables the sustainable production of real animal proteins without the use of a single animal.

EVERY’s fermentation process ensures consistent production of high-quality and highly-functional egg proteins, using significantly less water, land, and energy and generating fewer greenhouse gas emissions than animal-derived egg protein.